SMAD4’s role as a central mediator in the TGF-β signaling pathway, regulating key cellular processes such as proliferation, differentiation, and apoptosis, is well-documented, with its involvement in cancer highlighting its potential as a therapeutic target. The gene discussed is SMAD4; the disease is cancer.